X. da; Alonso, L. K.; Doering-Silveira, E. (2005). Ayahuasca in adolescence: qualitative results. Journal of Psychoactive Drugs, 37(2), 135139.Doering-Silveira, E.; Grob, C. S.; Dobkin de Rios, M.; Lopez, E.; Alonso, L. K.; Tacla, C. et al. (2005). Report on psychoactive drug use among adolescents using ayahuasca within a religious context. Journal of Psychoactive Drugs, 37(2), 141-144.Doering-Silveira, E.; Lopez, E.; Grob, C. S.; Dobkin de Rios, M.; Alonso, L. K.; Tacla, C. et al. (2005). Ayahuasca in adolescence: a neuropsychological assessment. Journal of Psychoactive Drugs, 37(2), 123-128.Fabregas, J. M.; Gonzalez, D.; Fondevila, S.; Cutchet, M.; Fernandez, X.; Barbosa, P. C. R. et al. (2010). Assessment of addiction severity among ritual users of ayahuasca. Drug and Alcohol Dependence, 111(3), 257261.Fortunato, J. J.; Reus, G. Z.; Kirsch, T. R.; Stringari, R. B.; Fries, G. R.; Kapczinski, F. et al. (2010). Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. Journal of Neural Transmission, 117, 1-7.Gable, R. S. (2007). Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction, 102(1), 2434.Grob, C. S.; McKenna, D. J.; Callaway, J. C.; Brito, G. S.; Neves, E. S.; Oberlaender, G. et al. (1996). Human psychopharmacology of Hoasca: A plant hallucinogen used in ritual context in Brazil. The Journal of Nervous and Mental Disease, 184(2), 86-94.Halpern, J. H.; Sherwood, A. R.; Hudson, J. I.; Yurgelun-Todd, D.; Pope Jr.; H. G., (2005). Psychological and cognitive effects of long-term peyote use among Native Americans. Biological Psychiatry, 58, 624631.Halpern, J. H.; Sherwood, A. R.; Passie, T.; Blackwell, K. C.; Ruttenber, A. J. (2008). Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Medical Science Monitor, 14(8), SR15-SR22.Haywood, P. (2011). County rejects temple for UDV. The New Mexican. Disponivel em: http://www.santafenewmexican.com/Local%20News/arroyohondo-County-rejects-UDV-s-project.Jones, R. T. (2009). Hallucinogen-related disorders. In: Sadock, B. J.; Sadock, V. A.; Ruiz, P. (Eds.). Kaplan and Sadocks comprehensive textbook of psychiatry. 9. ed. Philadelphia: Lippincott Williams and Wilkins, p. 13311340.La Barre, W.; McAllester, D. P.; Slotkin, J. S.; Stewart, O. C.; Tax, S. (1951). Statement on peyote. Science, 114(2970), 582-583.Labate, B. C. (2012). Paradoxes of ayahuasca expansion: The UDV-DEA agreement and the limits of freedom of religion. Drugs: Education, Prevention and Policy, 19(1), 19-26._______; Feeney, K. (2012). Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. International Journal of Drug Policy, 23 (2): 154-161_______; Goldstein, I. (2009). Ayahuasca From dangerous drug to national heritage: An interview with Antonio A. Arantes. International Journal Transpersonal Studies, 28, 53-64._______; Jungaberle, H. (Eds.). (2011). The internationalization of ayahuasca. Zurich: Lit Verlag._______; MacRae, E. (Eds.). (2010). Ayahuasca, ritual and religion in Brazil. London: Equinox._______; Rose, I. S.; Santos, R. G. (2008). Religioes ayahuasqueiras: um balanco bibliografico. Campinas: Mercado de Letras._______; Santos, R. G.; Anderson, B.; Mercante, M.; Barbosa, P. C. R. (2010). The treatment and handling of substance dependence with ayahuasca: Reflections on current and future research. In: Labate, B. C.; MacRae, E. (Eds.). Ayahuasca, ritual and religion in Brazil. London: Equinox. p. 205-227.Lima, F. A. S.; Tofoli, L. F. (2011). An epidemiological surveillance system by the UDV: